Ethylbenzatropine for acute neurological and mental side effects after tranquillisers.
D000978:Antiparkinson Agents / Q000627:therapeutic use; D001480:Basal Ganglia Diseases / Q000139:chemically induced / Q000188:drug therapy; D003692:Delayed-Action Preparations; D005260:Female; D006801:Humans; D001523:Mental Disorders / Q000188:drug therapy*; D009069:Movement Disorders / Q000188:drug therapy*; D014149:Tranquilizing Agents / Q000009:adverse effects*; D014326:Tropanes / Q000627:therapeutic use*
D000978:Antiparkinson Agents; D003692:Delayed-Action Preparations; D014149:Tranquilizing Agents; D014326:Tropanes